Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gould

Showing results (211-220 of 225) with videos related to

Pageof 23
Sort By:
Journal of Medicinal Chemistry|October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural productP D Williams, M G Bock, R D Tung, et al.
Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
Journal of Medicinal Chemistry|October 16, 1992
Orally active, nonpeptide oxytocin antagonistsB E Evans, J L Leighton, K E Rittle, et al.
Journal of Medicinal Chemistry|July 1, 1990
Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modificationsR M Freidinger, P D Williams, R D Tung, et al.
Journal of Medicinal Chemistry|February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivativesW F Hoffman, A W Alberts, E J Cragoe, et al.
Diabetologia|February 14, 2012
Enhanced beta cell proliferation in mice overexpressing a constitutively active form of Akt and one allele of p21CipM Blandino-Rosano, E U Alejandro, A Sathyamurthy, et al.
Journal of Medicinal Chemistry|March 1, 1983
Prostaglandin isosteres. 2. Chain-modified thiazolidinone prostaglandin analogues as renal vasodilatorsJ B Bicking, M G Bock, E J Cragoe, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 3, 2015
Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humansGary David Bowers, Amanda Culp, Melinda J Reese, et al.
Developmental Cell|April 21, 2023
Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cellsValeria Amodeo, Timothy Davies, Amalia Martinez-Segura, et al.
Nature|March 16, 2023
The dietary sweetener sucralose is a negative modulator of T cell-mediated responsesFabio Zani, Julianna Blagih, Tim Gruber, et al.
Pageof 23

Showing results (211-220 of 225) with videos related to

Sort By:
Pageof 23
Journal of Medicinal Chemistry|October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural productP D Williams, M G Bock, R D Tung, et al.
Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
Journal of Medicinal Chemistry|October 16, 1992
Orally active, nonpeptide oxytocin antagonistsB E Evans, J L Leighton, K E Rittle, et al.
Journal of Medicinal Chemistry|July 1, 1990
Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modificationsR M Freidinger, P D Williams, R D Tung, et al.
Journal of Medicinal Chemistry|February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivativesW F Hoffman, A W Alberts, E J Cragoe, et al.
Diabetologia|February 14, 2012
Enhanced beta cell proliferation in mice overexpressing a constitutively active form of Akt and one allele of p21CipM Blandino-Rosano, E U Alejandro, A Sathyamurthy, et al.
Journal of Medicinal Chemistry|March 1, 1983
Prostaglandin isosteres. 2. Chain-modified thiazolidinone prostaglandin analogues as renal vasodilatorsJ B Bicking, M G Bock, E J Cragoe, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 3, 2015
Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humansGary David Bowers, Amanda Culp, Melinda J Reese, et al.
Developmental Cell|April 21, 2023
Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cellsValeria Amodeo, Timothy Davies, Amalia Martinez-Segura, et al.
Nature|March 16, 2023
The dietary sweetener sucralose is a negative modulator of T cell-mediated responsesFabio Zani, Julianna Blagih, Tim Gruber, et al.
Pageof 23